CeMMEC1
CAS No. 440662-09-9
CeMMEC1 ( CeMMEC 1 )
Catalog No. M14499 CAS No. 440662-09-9
CeMMEC1 is a potent, selective second bromodomain of TAF1 inhibitor with Kd of 1.8 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | In Stock |
|
10MG | 72 | In Stock |
|
25MG | 160 | In Stock |
|
50MG | 290 | In Stock |
|
100MG | 431 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCeMMEC1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCeMMEC1 is a potent, selective second bromodomain of TAF1 inhibitor with Kd of 1.8 uM.
-
DescriptionCeMMEC1 is a potent, selective second bromodomain of TAF1 inhibitor with Kd of 1.8 uM; shows high selectivity for the TAF1 (2) bromodomain over BRD4 (1), BRD9, CREBBP, EP300 and TAF1 (2) bromodomains (IC50>10 uM; impaires cell viability in TAF1 downregulated cells; synergizes with (+)-JQ1 to inhibit the proliferation of THP-1 and H23 lung adenocarcinoma cells.
-
SynonymsCeMMEC 1
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBRD4;TAF1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number440662-09-9
-
Formula Weight336.30
-
Molecular FormulaC19H16N2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 21 mg/mL (62.4 mM) ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESCN1C=C(C2=CC=CC=C2C1=O)C(=O)NC3=CC4=C(C=C3)OCCO4
-
Chemical NameN-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,2-dihydro-2-methyl-1-oxo-4-isoquinolinecarboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sdelci S, et al. Nat Chem Biol. 2016 Jul;12(7):504-10.
molnova catalog
related products
-
INCB057643
INCB057643 is a novel potent, selective, orally bioavailable BET inhibitor.
-
ZL0454
ZL0454 is a potent, highly selective small-molecule BRD4 inhibitor with IC50 of 49 and 32 nM for BRD4-BD1 and BRD4-BD2, respectively.
-
LP99
LP99 is the first potent and selective BRD7/9 bromodomain inhibitor with Kd of 99 nM for BRD9; inhibits IL‐6 secretion from THP‐1 cells in a dose‐dependent manner.